Curis
CRIS
#10257
Rank
S$28.26 M
Marketcap
S$0.71
Share price
3.17%
Change (1 day)
-64.23%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.72. In 2024 the company made an earnings per share (EPS) of S-$9.04 an increase over its 2023 EPS that were of S-$11.61.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-46.06%
2024S-$9.04-22.15%
2023S-$11.61-26.17%
2022S-$15.7222.3%
2021S-$12.86-25.37%
2020S-$17.23-30.93%
2019S-$24.94-2.02%
2018S-$25.45
2016S-$57.85-10%
2015S-$64.28138.1%
2014S-$27.0040%
2013S-$19.28-25%
2012S-$25.7166.67%
2011S-$15.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.75-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.45-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$3.72-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.00 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.45 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.81-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA